The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Transforming Acute Hospital Care To Improve Outcomes For Stroke
Funder
National Health and Medical Research Council
Funding Amount
$1,350,000.00
Summary
Stroke is severely disabling but patients do not always receive the best care. I will lead rigorous research to improve stroke care in the emergency department and stroke units. I will help clinicians implement evidence-based stroke care, including protocols to manage fever, raised glucose and swallowing difficulties across Australia and internationally. Results will be relevant globally, informing strategies to drive practice change and improve patient outcomes.
Caring For Clinician Health And Wellbeing; Protecting Patients From Harm
Funder
National Health and Medical Research Council
Funding Amount
$1,281,125.00
Summary
Doctors and other clinicians care for the health of others but their own health can also suffer. In turn, unwell clinicians may place patients at risk of harm. My research will analyse ten years of data from the Medical Board and other regulators, interview clinicians who have had a serious illness, and work with international experts to develop solutions. Together, this work will help hospitals and regulators to better protect the health of clinicians and safeguard patients from avoidable harm.
Targeted Approaches To Improve Health Outcomes In Severe Respiratory Disease
Funder
National Health and Medical Research Council
Funding Amount
$645,205.00
Summary
Despite receiving optimal treatment, people with severe lung disease experience distressing symptoms, reduced quality of life and wellbeing, and poor health outcomes. This transformational research will investigate new treatment approaches: an integrated palliative care program and Nasal High Flow therapy at home, to identify benefits for people with lung disease. Additionally this research will examine how patients’ attitudes to illness distress and mental health affect wellbeing and health
Reducing The Burden Of Breast Cancer Through Precision Prevention, Targeted Treatment And Enhanced Survivorship
Funder
National Health and Medical Research Council
Funding Amount
$1,491,192.00
Summary
Breast cancer affects 1 in 8 Australian women. Of all the cancers, breast cancer results in the largest number of years of healthy life lost from death and illness. My research will reduce this unacceptable burden of breast cancer for women and their families. Spanning prevention, through treatment to survivorship, it will facilitate reduced breast cancer incidence, more effective treatments and enhanced understanding of the effects of new treatments on ovarian function and fertility.
Multi-dimensional Monitoring Of Cognition And Cerebellar Function To Prospectively Define Disease Progression In Multiple Sclerosis
Funder
National Health and Medical Research Council
Funding Amount
$1,462,250.00
Summary
Multiple Sclerosis (MS) is an autoimmune degenerative brain disease that cost Australia >$1.7 billion/year in lost productivity. An estimated 50% of people with MS (pwMS) develop unrelenting, progressive disability (secondary progressive MS, SPMS). SPMS is currently diagnosed retrospectively by observing inexorable worsening in neurological function without relapses for > 6 month
Improving Patient-important Outcomes In Haemodialysis Through Validation And Implementation In Registries And Pragmatic Clinical Trials
Funder
National Health and Medical Research Council
Funding Amount
$408,082.00
Summary
Haemodialysis is the most common treatment for kidney failure but is associated with poor survival, high symptom burden and drastically reduced quality of life. Research often does not address these patient-important outcomes, thereby limiting our ability to discover effective interventions. This program aims to improve haemodialysis outcomes that are critically important to patients and clinicians through validation and implementation in clinical practice, registries and clinical trial.
Patient-centred Volunteer Program For People With Dementia: A Stepped Wedge Cluster Randomised Controlled Trial Of The MyCare Ageing Program
Funder
National Health and Medical Research Council
Funding Amount
$645,205.00
Summary
The MyCare Ageing program provides hospitalised patients with dementia and/or delirium with tailored emotional and practical support via trained volunteers in hospital and in the transition home. This project will provide critical information on whether MyCare Ageing works to reduce future hospitalisations and prevent poor patient outcomes, the factors that impact on how the program is delivered in hospital and in the community, and whether the program is cost-effective.
Partnering With Patients To Transform Practice And Policy For Improved Patient-centred Outcomes In Chronic Kidney Disease
Funder
National Health and Medical Research Council
Funding Amount
$3,292,932.00
Summary
Chronic kidney disease (CKD) is a major cause of death and imposes a substantial burden on individuals and the healthcare system worldwide. In partnership with patients, this project will establish and implement core outcomes and measures. Patient-centred trials will address the research priorities of patients across all stages of CKD including: preventing the progression of CKD, improving fatigue in patients on dialysis, and optimising life participation in kidney transplant recipients.
Fighting Retinal Blindness: Learn From The Past, Improve The Present And Explore The Future Of Treatments For Macular Diseases.
Funder
National Health and Medical Research Council
Funding Amount
$2,039,951.00
Summary
MG is a clinician-scientist dedicated to improving outcomes in people with macular disease. His lab research unit studies the causes and looks for new treatments for macular disease. His clinical research unit focuses on clinical trials of new treatments, both large multinational studies and other smaller studies where we test our own ideas. His observational unit analyses the outcomes of treatment in “real world” clinical practice. These 3 units will work together to fight macular blindness.